1-9 of 9
Paresh Vyas, DPhil, FRCP, FRCPath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Mutant Haemopoietic Transcription Factor GATA1s on Haemopoiesis

Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath, Gaetan Juban, PhD, Nathalie Sakakini, PhD, Kelly Soady, PhD, Hedia Chagraoui, PhD, Bilyana Stoilova, PhD, Catherine Garnett, Ludovic Lhermitte, MD, Elena Karkoulia, PhD, John Strouboulis, PhD, Catherine Porcher, PhD, Irene Roberts, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3798.
https://doi.org/10.1182/blood.V130.Suppl_1.3798.3798
Published: 2017
Journal Articles

Mature Analysis of the Prospective Oxford Down Syndrome (DS) Cohort Study: Timing and Clinical Impact of Preleukemic GATA1 Mutations and Lessons for Management of Newborns with DS

Irene Roberts, MD, Neha Bhatnagar, ND, Amelie Chaussade, MD, Laure Nizery, MD, Helen Richmond, RSCN, Natalina Elliott, PhD, Gemma Buck, BSc, Marlen Metzner, MSc, Alison Kennedy, MSc, Catherine Garnett, Kelly Perkins, PhD, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 569.
https://doi.org/10.1182/blood.V130.Suppl_1.569.569
Published: 2017
Journal Articles

Mutant Isocitrate Dehydrogenase (mIDH) Inhibitors, Enasidenib or Ivosidenib, in Combination with Azacitidine (AZA): Preliminary Results of a Phase 1b/2 Study in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

Courtney D. DiNardo, MDMSc, Anthony S. Stein, MD, Amir T. Fathi, MD MD BS, Pau Montesinos, MD PhD, Olatoyosi Odenike, MD, Hagop M. Kantarjian, MD, Richard M. Stone, MD, Daniel O. Koralek, PhD, Jason Van Oostendorp, M.Sc., Jing Gong, PhD, Ira Gupta, MD, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 639.
https://doi.org/10.1182/blood.V130.Suppl_1.639.639
Published: 2017
Journal Articles

Clonal Heterogeneity in Differentiation Response and Resistance to the IDH2 Inhibitor Enasidenib in Acute Myeloid Leukemia

Lynn Quek, FRCPath, DPhil, MBBS, Muriel David, Alison Kennedy, MSc, Marlen Metzner, MSc, Michael Amatangelo, PhD, Alan H. Shih, MD PhD, Bilyana Stoilova, PhD, Dimitris Karamitros, PhD, Cyril Quivoron, Mael Heiblig, MD, Christophe Willekens, MD, Veronique Saada, Andrew Peniket, Olivier Bernard, Sam Agresta, MD, Katharine Yen, Eytan M. Stein, MD, Stephane De Botton, Anjan Thakurta, PhD, Ross L. Levine, MD, Virginie Penard-Lacronique, PhD, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 724.
https://doi.org/10.1182/blood.V130.Suppl_1.724.724
Published: 2017
Journal Articles

Safety and Clinical Activity of Combined Romidepsin and Azacitidine Therapy in High Risk Acute Myeloid Leukemia: Preliminary Results of the Romaza Trial

Charles Craddock, Eleni Tholouli, MD PhD, Samuel Munoz Vicente, MSc, Emmanouela Gbandi, BSc, MSc, MScM, PhD, Aimee E Houlton, BSc, MSc, Mark W Drummond, MB ChB, PhD FRCPath, Jiri Pavlu, MD, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 2581.
https://doi.org/10.1182/blood.V130.Suppl_1.2581.2581
Published: 2017
Journal Articles

A Novel Model of Human Hemopoiesis Based on Single Cell Functional and Transcriptional Analysis of Lympho-Myeloid Progenitors

Bilyana Stoilova, PhD, Dimitris Karamitros, PhD, Zahra Aboukhalil, Fiona Hamey, Andreas Reinisch, MD PhD, Marina Samitsch, PhD, Lynn Quek, FRCPath, DPhil, MBBS, Georg Otto, PhD, Emmanouela Repapi, PhD, Jessica Doondeea, Batchimeg Usukhbayar, Julien Calvo, PhD, Stephen Taylor, PhD, Nicolas Goardon, PhD, Emmanuelle Six, Francoise Pflumio, PhD, Catherine Porcher, PhD, Ravi Majeti, MD PhD, Berthold Gottgens, PhD, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 2413.
https://doi.org/10.1182/blood.V130.Suppl_1.2413.2413
Published: 2017
Journal Articles

Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative- Allogeneic Hematopoietic Cell Transplantation

Charlotte Ann Bradbury, MA BM BCh MRCP FRCPATH, Janice Ward, Paresh Vyas, DPhil, FRCP, FRCPath, Nigel H. Russell, MD, Grimwade David, Robert K Hills, Alan K. Burnett, Charles F. Craddock, BM, MRCP, MRCPath, Freeman Sylvie
Journal: Blood
Blood (2012) 120 (21): 4098.
https://doi.org/10.1182/blood.V120.21.4098.4098
Published: 2012
Journal Articles

Azacitidine Induces Expansion of Regulatory T Cells and Tumour Specific CD8+ T Lymphocytes After Allogeneic Stem Cell Transplantation: A Strategy for Epigenetic Manipulation of a Graft-Versus-Leukemia Response

Mike Dennis, Oliver Goodyear, Justin Loke, Nadiria Jilani, Shamyla Siddique, Gordon Ryan, Rehela Khanum, John Snowden, Michael Griffiths, PhD, Nigel H. Russell, MD, John Yin, MD, Charles Crawley, MD, Gordon Cook, MD, PhD, Paresh Vyas, DPhil, FRCP, FRCPath, Paul AH Moss, MD PhD, Ram Malladi, Charles F. Craddock, BM, MRCP, MRCPath
Journal: Blood
Blood (2011) 118 (21): 324.
https://doi.org/10.1182/blood.V118.21.324.324
Published: 2011
Journal Articles

Reduced CD38 Expression on CD34+ Cells as a Diagnostic Test in Myelodysplastic Syndromes

Paresh Vyas, DPhil, FRCP, FRCPath, Nicolas Goardon, PhD, Alexander Sternberg, MRCP, FRCPath, Wai-Kit Chu, Charles F. Craddock, BM, MRCP, MRCPath, Richard Benson, FRCS, Sylvie Freeman, BM, MRCP, FRCPath
Journal: Blood
Blood (2008) 112 (11): 2670.
https://doi.org/10.1182/blood.V112.11.2670.2670
Published: 2008